License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Background. The prognostic significance of ERG expression in prostate cancer (PCA) has generated mixed results. We sought to investigate the prognostic significance of ERG expression in a localized cohort of men with PCA. Material and Methods. We investigated ERG protein expression in a cohort of 198 men with localized PCA. ERG expression was correlated with patients’ clinical outcome and several pathological parameters, including Gleason score (GS), pathological stage, surgical margin, and extra-capsular extension. Results. ERG expression was detected in 86/198 (43.4%) patients exclusively in neoplastic epith...
Objective: To investigate the incidence ERG fusion positive adenocarcinoma and its correlation with ...
In this review we briefly discuss the possible biomarkers of prostate cancer among them we focus and...
Objectives: Phosphate and tensin homolog gene (PTEN) acts as a regulator of P13-K-Akt molecular path...
International audienceTMPRSS2/ERG fusion resulting in ERG overexpression occurs in 30 to 50% of pros...
Prognostic biomarkers for prostate cancer are needed to improve prediction of disease course and gui...
OBJECTIVES: To assess the prognostic value of ERG and PTEN protein expression as two of the most com...
The second most prevalent cancer among men with a 5-year survival rate of 30%, prostate cancer is a ...
PURPOSE: To evaluate associations between pathologic factors and erythroblast transformation-speci...
<p>Patients are separated into two groups depending on presence of ERG expression (dashed line) or a...
in prostate cancer (PC) and evaluate their prognostic significance. Despite conflicting published r...
Abstract Objectives T/E fusion results in constitutive expression of ERG oncoprotein resulting in en...
© American Society for Clinical Pathology. Objectives: The proto-oncogene ETS-related gene (ERG) is ...
none23siBACKGROUND: Whether the genomic rearrangement transmembrane protease, serine 2 (TMPRSS2):...
OBJECTIVE To integrate the mapping of ERG alterations with the collection of expression microarray (...
Introduction: Prostate cancer is a heterogenous disease and the mechanisms that drive it to behave d...
Objective: To investigate the incidence ERG fusion positive adenocarcinoma and its correlation with ...
In this review we briefly discuss the possible biomarkers of prostate cancer among them we focus and...
Objectives: Phosphate and tensin homolog gene (PTEN) acts as a regulator of P13-K-Akt molecular path...
International audienceTMPRSS2/ERG fusion resulting in ERG overexpression occurs in 30 to 50% of pros...
Prognostic biomarkers for prostate cancer are needed to improve prediction of disease course and gui...
OBJECTIVES: To assess the prognostic value of ERG and PTEN protein expression as two of the most com...
The second most prevalent cancer among men with a 5-year survival rate of 30%, prostate cancer is a ...
PURPOSE: To evaluate associations between pathologic factors and erythroblast transformation-speci...
<p>Patients are separated into two groups depending on presence of ERG expression (dashed line) or a...
in prostate cancer (PC) and evaluate their prognostic significance. Despite conflicting published r...
Abstract Objectives T/E fusion results in constitutive expression of ERG oncoprotein resulting in en...
© American Society for Clinical Pathology. Objectives: The proto-oncogene ETS-related gene (ERG) is ...
none23siBACKGROUND: Whether the genomic rearrangement transmembrane protease, serine 2 (TMPRSS2):...
OBJECTIVE To integrate the mapping of ERG alterations with the collection of expression microarray (...
Introduction: Prostate cancer is a heterogenous disease and the mechanisms that drive it to behave d...
Objective: To investigate the incidence ERG fusion positive adenocarcinoma and its correlation with ...
In this review we briefly discuss the possible biomarkers of prostate cancer among them we focus and...
Objectives: Phosphate and tensin homolog gene (PTEN) acts as a regulator of P13-K-Akt molecular path...